FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA has approved a supplemental application for Lipitor (atorvastatin calcium) submitted by Viatris Specialty LLC to update labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

SUPPL AP for LIPITOR (ATORVASTATIN CALCIUM)